UNSPSC 51285005: Amoxicillin trihydrate/Potassium clavulanate

The combination of amoxicillin and clavulanic acid is used to treat certain infections caused by bacteria, including infections of the ears, lungs, sinus, skin, and urinary tract. Amoxicillin is in a class of medications called penicillin-like antibiotics.

UNSPSC 51285005 Amoxicillin trihydrate/Potassium clavulanate is a Commodity code that classifies a specific antibiotic combination product, yet the recent state and local contract opportunities in the dataset show no active solicitations for this pharmaceutical. The most recent identified opportunity—an Invitation to Quote from Pinellas County, Florida, for certified reference materials used in forensic drug analysis (solicitation 260305ITQ, posted April 23, 2026)—targets drug standards for laboratory validation, not clinical pharmaceuticals. A second opportunity, Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023), sought naloxone and drug deactivation systems for community health—a public health intervention product distinct from this code's scope. The City of Tucson Fire Department's RFP 260217 (posted June 24, 2026, due June 24, 2026) for basic and advanced life support pharmaceuticals and supplies comes closest in medical application but does not specify amoxicillin/clavulanate procurement. Across the dataset, vendor networking and reverse trade show events dominate posted notices, with no formal competitive solicitations directly targeting this antibiotic combination.

The absence of recent amoxicillin trihydrate/potassium clavulanate procurement activity in state and local records suggests either low direct-buy frequency under this specific code or procurement bundling under broader pharmaceutical family codes. When jurisdictions do acquire this product, they likely consolidate it within multi-source generic pharmaceutical agreements—such as the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP S1070000015802 (posted January 20, 2026, due March 26, 2026)—which establish frameworks for wholesaler distribution across participating state, county, and municipal health facilities. Opportunities in this commodity space tend to flow through established cooperative purchasing vehicles and authorized wholesalers rather than as standalone solicitations. Geographic activity when present concentrates in Florida and the upper Midwest, where formal pharmaceutical cooperative agreements generate the bulk of state and local contracting. The code itself remains quiet relative to broader antibiotic and generic pharmaceutical procurement categories, warranting monitoring of cooperative vehicle RFPs and health department consumables contracts rather than standalone opportunities.